National Academies Press: OpenBook

Global Health Risk Framework: Pandemic Financing: Workshop Summary (2016)

Chapter: Appendix C: Participant Biographies

« Previous: Appendix B: Workshop Agenda
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Appendix C

Participant Biographies

Jennifer Adams, M.Phil., Ph.D., is Deputy Assistant Administrator in the Bureau for Global Health at the U.S. Agency for International Development (USAID). She is responsible for the strategic direction and management of USAID’s programs in health systems, population and reproductive health, HIV/AIDS, and global health security. The global health bureau is comprised of more than 450 staff members, and health programming constitutes one-third of USAID’s total budgetary resources.

Prior to this assignment, Dr. Adams headed USAID’s Office of Donor Engagement, directing USAID’s analysis, communication, and collaborative efforts to generate joint understanding and action on key development priorities with both bilateral and multilateral donor partners around the world. Dr. Adams was appointed the first USAID Development Counselor to China in September 2008. Before her post in Beijing, she was the Mission Director for USAID in Brazil. Dr. Adams has worked for USAID for more than 20 years as a Foreign Service Officer. Her posts include the Central Asian Republics, Senegal, Brazil, and Washington, DC. Her positions included economist, and managing social sector portfolios, including health, education, and environment projects. In Brazil, she initiated a successful public–private partnership, Mais Unidos, that engaged the 50 largest American companies to support social entrepreneurship.

Dr. Adams graduated from Johns Hopkins University, has an M.Phil. from the Institute of Development Studies at the University of Sussex, where she was a Marshall Scholar, and a Ph.D. in economics from Cambridge University.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Victor Bampoe, M.D., a Ghanaian national, is the Deputy Minister of Health in his country—a role he has held for a year. Dr. Bampoe is also the Incident Commander of Ghana’s Ebola Emergency Operations Center (EOC). Before being appointed by President John Mahama of Ghana to this role, Dr. Bampoe was a Senior Fund Portfolio Manager at the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria based in Geneva, Switzerland. In that role, Dr. Bampoe was responsible for managing grants to fight the three diseases in South Africa, with a total value of more than $800 million. Dr. Bampoe worked at the Global Fund in various capacities from 2005: he served as the Fund Manager in Kenya, Rwanda, Uganda, and Zambia, and was also the Risk Manager, as well as the Team Leader for Southern Africa. Before he took up his role at the Global Fund, Dr. Bampoe worked with the UK Department for International Development (DFID) as a Regional Health and HIV Adviser, and before that as a Medical Officer with the Ministry of Health in Ghana.

Dr. Bampoe is a medical doctor by training, with a specialization in public health obtained at the prestigious Johns Hopkins School of Hygiene and Public Health in Baltimore, Maryland.

Priya Basu, M.A., M.Sc., is currently Manager in the World Bank’s Development Finance Vice-presidency. Her department bridges the World Bank Group with external partners to design and manage game-changing, innovative finance initiatives to serve critical development priorities. Since joining the World Bank in Washington, DC, in 1998 as a Young Professional, Ms. Basu has held various operational positions, leading lending and policy work in the areas of infrastructure financing, financial sector development, financial access for the poor, and small and medium enterprise development in countries across South Asia, East Asia, Europe and Central Asia, and sub-Saharan Africa. From 2005 to 2009 she served as the Bank’s Lead Financial Economist for India based in the country office. Prior to joining the Bank, Ms. Basu worked in investment banking in London. She has previously worked as an economist at the International Monetary Fund (IMF) in Washington, DC, at the Asian Development Bank in Manila, and at United Nations Conference on Trade and Development (UNCTAD) in Geneva. Ms. Basu holds a B.A. (Hons.) degree in economics from Delhi University, a B.A./M.A. in politics, philosophy, and economics from Merton College, University of Oxford, United Kingdom, and an M.Sc. in development economics from the University of Oxford. She is the author of three books: Creating Resilient Financial Regimes in Asia (Oxford University Press, 1998), India’s Financial Sector: Challenges and Policy Options (Macmillan, 2005), and Improving Access to Finance in India (World Bank, 2006).

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Aron Betru, M.B.A., M.A., CEO of Financing for Development (F4D), specializes in innovative financing solutions for international development. Mr. Betru is a pioneer in guarantee-backed financing of public health commodities, facilitating millions of dollars in both commercial lending for malaria and trade financing for reproductive health. He has also facilitated stakeholder price negotiations between procurers and suppliers that have yielded millions of dollars’ worth of increased access for commodity users. Mr. Betru served as a member of the Bellagio Consensus of 2012 that advocated for multiple method–based promotion of long-acting reversible contraceptives, and was a strategic advisor on matters of market dynamics and country engagement for FP2020.

Prior to joining F4D’s flagship program, Pledge Guarantee for Health, during its proof of concept at the United Nations Foundation and facilitating its transfer to F4D, Mr. Betru was a project manager in the Washington, DC, office of Dalberg Global Development Advisors and a member of its Health, Access to Finance, and Strategy practices. Earlier in his career, he was a Senior Associate at McKinsey & Co.’s Philadelphia office and a Summer Associate at Goldman Sachs’ Investment Banking Division, where he supported a range of strategic analysis and financial transactional work for clients in the financial services, private equity, pharmaceutical, and government sectors.

Mr. Betru is a member of the Council on Foreign Relations and a regular contributor to the Global Health and Diplomacy magazine, writing on innovative finance in public health. He holds an M.B.A. from Columbia University’s Graduate School of Business, an M.A. in international relations from Johns Hopkins University’s School of Advanced International Studies, and a B.A. in economics and international studies from Northwestern University.

Tendai Biti is a Zimbabwean politician who served as Zimbabwe’s Minister of Finance from 2009 to 2013, a period which saw him turn around an economy that had been ravaged by hyperinflation of 500 billion percent and an unemployment rate up to 85 percent.

He is also the Secretary-General and a founding member of the Movement for Democratic Change Renewal Team. Mr. Biti rose to prominence after handling high-profile constitutional and labor cases, including a landmark case that saw the notorious Law and Order Maintenance Act, which did not allow demonstrations without police clearance, being repealed.

Adam Bornstein, M.B.A., has more than 20 years of emerging market investment, resource mobilization, and strategy experience in Asia and Africa. Mr. Bornstein is the Innovation Health Financing Specialist with

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

the Global Fund to Fight AIDS, Tuberculosis and Malaria based in Geneva, Switzerland. He is responsible for developing and structuring alternative funding products, working with government ministries, the private sector, and civil society to identify sustainable pools of health financing. He formerly was the International Finance Corporation’s resident representative in Mongolia and before that was senior vice president at CDIB Capital, a Hong Kong–based $1 billion private equity fund where he was responsible for direct investments in private and public companies across Asia. He earned a master’s degree in business administration from Boston University Graduate School of Management and is conversant in Mandarin Chinese and Mongolian.

Milan Brahmbhatt, M.Sc., is Senior Fellow at the World Resources Institute and a member of the project team for the New Climate Economy Initiative of the Global Commission on the Economy and Climate, where he leads the work of the Country Transitions workstream. Before joining the New Climate Economy, Mr. Brahmbhatt worked at the World Bank, as Senior Adviser to the Vice President of the Poverty Reduction and Economic Management Network, dealing with a wide range of macroeconomic and structural policy issues, including the economics of climate change, sustainable growth, and the economics of infectious diseases.

Gillian Buckley, Ph.D., M.P.H., is a Senior Program Officer in the Board on Population Health and Public Health Practice of the National Academies of Sciences, Engineering, and Medicine. She was study director for the consensus reports Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad, Countering the Problem of Falsified and Substandard Drugs, and Investing in Global Health Systems: Sustaining Gains, Transforming Lives. Dr. Buckley managed the Standing Committee to Support USAID’s Office of Health Systems. She holds a Ph.D. in human nutrition and an M.P.H. in international health, both from Johns Hopkins University; her dissertation examined the effects of prenatal vitamin A supplementation on the cognitive and motor development of Nepali children. She was a Peace Corps volunteer in Nepal from 2000 to 2002.

Juan Costain, M.Sc., a UK national, joined the World Bank in 1996 and recently returned to Washington, DC, to take up the position as Lead Financial Sector Specialist in the Africa region where he has been coordinating the Ebola response of the World Bank’s Finance and Markets practice. Mr. Costain’s prior recent experience has been as Regional Team Leader for South Asia for the Water and Sanitation Programme, a multidonor partnership administered by the World Bank to support poor people in obtaining affordable, safe, and sustainable access to water and sanitation services.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Mr. Costain has also held various positions at the World Bank in country program management and private- and financial-sector operations covering competitiveness, public–private partnership, public-sector reform, and financial-sector development in Africa and in South Asia.

Mr. Costain returned to the World Bank in 2003 after a 2-year leave of absence managing a specialized emerging market hedge fund in London. Prior to joining the World Bank, Mr. Costain had been employed since 1984 in a variety of investment banking functions at Kidder, Peabody, the investment banking subsidiary of General Electric, and at the Union Bank of Switzerland, based in London and Hong Kong, holding the position of Managing Director responsible for international capital markets, new issues, and emerging markets.

Mr. Costain holds an M.Sc. and a B.Sc. in monetary economics from the London School of Economics, as well as the Chartered Financial Analyst (CFA) designation.

David Crush, M.Sc., has been in the World Bank Group since 2009, first as part of the World Bank’s Innovative Finance team in Washington, DC, working with the Global Fund, Gavi, and the International Finance Facility for Immunisation (IFFIm). He moved to the International Finance Corporation (IFC) in 2011 to head IFC’s Access to Finance Advisory team in Sub-Saharan Africa and since 2014 he has been Practice Manager in the World Bank’s joint IFC/World Bank Finance and Markets Practice responsible for Sub-Saharan Africa.

Prior to the World Bank, Mr. Crush worked (from 1991 to 2009) for the European Investment Bank, the European Union’s development finance institution, in the United Kingdom (on financing public–private partnerships) as well as in the Africa, Caribbean and Pacific Department. From 1985 to 1991 Mr. Crush worked for Barclays Bank in the United Kingdom as Senior Economist for Africa and then as a manager in the Sovereign Lending department. He began his career with the UK government working at the African Development Bank in Abidjan, Cote d’Ivoire.

Mr. Crush is a graduate of Cambridge University and has an M.Sc. in agricultural economics from the University of Reading in the United Kingdom. He is also an Associate of the United Kingdom’s Chartered Institute of Bankers. In 2014 he was given the World Bank’s Excellence in Leadership Award.

Nikhil da Victoria Lobo, in his role in Global Partnerships, leads Swiss Re’s dialogue with governments, development banks, and nongovernmental organizations in the Americas. The team works on customized solutions to help the public sector manage and transfer their risk to the (re)insurance and capital markets.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Global Partnerships has successfully helped public-sector clients address such complex risks as natural catastrophes, agriculture production, infrastructure financing, and longevity risk, and leverages Swiss Re’s broad product offerings. These range from traditional risk transfer to insurance-linked securities and advisory services.

Prior to his current role, Mr. da Victoria Lobo was an underwriter for Swiss Re’s corporate insurance business, focusing on the Latin America Fortune 500 companies. He joined Swiss Re in 2001 as an investment professional in Securitas Capital, a private equity firm focused in the insurance industry. He worked on a number of private and public transactions before joining Swiss Re’s Latin American reinsurance department as a deputy manager for finance and operations. Mr. da Victoria Lobo holds a degree in finance from The Wharton School of the University of Pennsylvania.

Katherine DeLand, J.D., M.P.H., as the Chief of Staff of the World Health Organization’s (WHO’s) Ebola Response, has worked closely with the Special Representative of the Director-General and Ebola Response Leader, WHO Country Offices in Guinea, Liberia, Mali, and Sierra Leone, the United Nations (UN) Mission on Emergency Ebola Response, and a diversity of UN agencies and nongovernmental organizations (NGOs) to help drive the efforts to eliminate Ebola in West Africa. Prior to holding this position, she founded DeLand Associates in 2011 to fill a growing niche for independent, flexible, highly trained, and responsive consulting, advising, and project management in international law, health, and public policy. Professionally, her focus has been on multilateral negotiations, large-scale public health project management and donor relationships, whole-of-government approaches to trade and health, and sustainable health and development policy design and implementation. She has worked in Australia, Kenya, Switzerland, and the United States for organizations as diverse as WHO, the L’Etwal Foundation, the World Bank, the U.S. Centers for Disease Control and Prevention (CDC), and the University of Sydney. She holds a B.A. in biochemistry and molecular biology from Reed College and a J.D. and an M.P.H. from the University of California, Los Angeles.

Victor J. Dzau, M.D., is the President of the National Academy of Medicine (NAM). In addition, he serves as Chair of the Institute of Medicine (IOM) Division Committee of the National Academies of Sciences, Engineering, and Medicine. Dr. Dzau is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as Chairman of the Department of Medicine at Stanford University.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Dr. Dzau has made a significant impact on medicine through his seminal research in cardiovascular medicine and genetics and his leadership in health care innovation. His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as widely used, life-saving drugs. In his role as a leader in health care, Dr. Dzau has led efforts in innovation to improve health, including the development of the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation.

As one of the world’s preeminent health leaders, Dr. Dzau advises governments, corporations, and universities worldwide. He has served as a member of the Advisory Committee to the Director of the National Institutes of Health (NIH) and as Chair of the NIH Cardiovascular Disease Advisory Committee. Currently he is a member of the Board of the Singapore Health System and Hamad Medical Corporation, Qatar. He was on the Board of Health Governors of the World Economic Forum and chaired its Global Agenda Council on Personalized and Precision Medicine.

Among his many honors and recognitions are the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Distinguished Scientist Award from the American Heart Association, the Ellis Island Medal of Honor, and the Henry Freisen International Prize. In 2014, he received the Public Service Medal from the President of Singapore. He is a member of the NAM, the American Academy of Arts and Sciences, and the European Academy of Sciences and Arts. He has received eight honorary doctorates.

Christopher Egerton-Warburton (Edge), M.A., is a founding partner of Lion’s Head Global Partners, a London- and Nairobi-based merchant bank. At Lion’s Head, Mr. Edge leads the firm’s activities in the global health field. Recently, Lion’s Head designed and established the Global Health Investment Fund, the first impact-focused investment fund dedicated to global health research and development. Prior to establishing Lion’s Head, Mr. Edge was the lead banker on the establishment of a new $5.5 billion multilateral development institution, the International Finance Facility for Immunisation (IFFIm), which funds Gavi, the Vaccine Alliance. Currently, Mr. Edge is a member of the IFFIm Board of Directors.

Mr. Edge commenced his career at Goldman Sachs where he spent 14 years within the Debt Capital Markets group. In his last role he was Head of the Sovereign, Supranational and Agency team. He spent 6 years within the Eastern Europe, Middle East, and Africa (EEMEA) emerging markets team, where he worked primarily in Hungary, Israel, South Africa, and Turkey. Mr. Edge received an M.A. in biochemistry from Christ Church College at Oxford University.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Elizabeth Emanuel, M.Sc., is an international development consultant and has more than 15 years’ development experience working in a range of areas including protected areas and biodiversity management; wastewater management; climate change adaptation; environmental education, training, and communication services; sustainable development planning; policy development; energy management and project management; and, most recently, providing advice to advance the green economy in the Caribbean. She works extensively with development partners such as the World Bank, the UN Economic Commission for Latin America and the Caribbean, the UN Environment Programme (UNEP), the UN Development Programme (UNDP), The Nature Conservancy, and the Global Environment Facility (GEF) Integrating Watershed and Coastal Area Management project, among others. She also has experience working a range of regional and international projects such as the Caribbean Catastrophe Risk Insurance Facility (renamed CCRIF SPC), the Inter-American Development Bank (IDB)/UNEP Caribbean Regional Wastewater Progamme, the Nile Basin Trust Fund, and the Cooperation for International Waters in Africa. In the Caribbean, Ms. Emanuel has worked for a range of governments—chief among these being Aruba, the Bahamas, Guyana, Jamaica, and Montserrat—developing national development plans and other national policies. She lectures at the master’s level at the University of the West Indies in the areas of environmental policy and sustainability, environmental economics, and natural resource valuation. She holds a B.Sc. in economics, an M.Sc. in development studies (concentration in environmental and health economics), and post-graduate diplomas in communications, public-sector management, public policy, public procurement, project management, and corporate governance.

Gabrielle Fitzgerald, M.P.A., was the Director of the Paul G. Allen Ebola Program, where she oversaw Paul Allen’s $100 million commitment to combat the Ebola outbreak in West Africa. Ms. Fitzgerald previously served as the Director of Global Program Advocacy at The Bill & Melinda Gates Foundation, overseeing the policy and advocacy agenda for the foundation’s 14 global programs. In this role, Ms. Fitzgerald led efforts that raised $1.3 billion in funding from new philanthropists to tackle global health problems, and oversaw the Global Vaccine Summit, held in Abu Dhabi in 2013, which brought together global leaders and stakeholders who committed $4 billion to delivering a polio-free world by 2018.

During Ms. Fitzgerald’s tenure at the foundation, she spearheaded their efforts to put malaria on the global agenda—including starting the United Against Malaria campaign, which won PR Week’s Global Campaign of the Year in 2014. For her leadership, in April 2014 she was awarded the Johns Hopkins Bloomberg School of Public Health’s Gold Medallion award. Prior

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

to joining the foundation, Ms. Fitzgerald spent 5 years at USAID, leading the public affairs strategy for the world’s largest funder of HIV/AIDS programs. Previously, she served as the communications director for the U.S. Committee for Refugees. She started her career as a speechwriter for President Bill Clinton at the White House. Ms. Fitzgerald holds a master’s of public administration from the Maxwell School at Syracuse University and a bachelor of arts from American University in Washington, DC.

George Fu Gao, D.Phil. (Oxon), is a Member of the Chinese Academy of Sciences (CAS), Fellow of The World Academy of Sciences (TWAS), Fellow of the American Academy of Microbiology, and Director and Professor in the CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences. Dr. Gao is also the Vice-President of the Beijing Institutes of Life Science, Chinese Academy of Sciences, and Deputy Director-General of the Chinese Center for Disease Control and Prevention (China CDC).

He obtained his Ph.D. (D.Phil.) degree in 1995 from Oxford University, United Kingdom. He was selected in the Chinese Academy of Sciences “Hundred Talents” program in 2004, and received the National Natural Science Foundation of China (NSFC) Distinguished Young Scholar title in 2005. He is the chief scientist of two consecutive 973 Projects, “mechanism of interspecies transmission of viral pathogens” (2005, 2011), and a leading principal investigator of the NSFC Innovative Research Group. He is also a steering committee member of International Consortium of Anti-Virals, and visiting professor in Oxford University, United Kingdom. He was awarded TWAS prizes in medical sciences in 2012 and was awarded the Nikkei Asia Prize in 2014.

His research focuses on mechanisms of interspecies transmission (“host jump”) of pathogens, especially interaction between the enveloped viruses and host, and molecular immune recognition. He has published more than 330 refereed papers.

Gargee Ghosh, M.Sc., Director of Development Policy and Finance, leads The Bill & Melinda Gates Foundation’s international policy team that supports ideas and innovations in policymaking—at the global and national levels—to advance human development and address extreme poverty. The team also provides independent analysis and recommendations to the foundation co-chairs and leaders on medium-range trends in development policy.

Ms. Ghosh previously held senior positions at Google.org and in the international development practice of McKinsey & Company, as well as at the Center for Global Development. From 2005 to 2009, she worked in the Gates Foundation’s Global Health division, where she helped launch significant efforts in immunization financing and impact investing. In addi-

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

tion to her foundation responsibilities, Ms. Ghosh is currently serving a 2-year term on President Barack Obama’s Global Development Council.

Ms. Ghosh holds graduate degrees in economics from the University of Oxford and in international relations from Georgetown University and she has a bachelor’s degree in economics from the University of Victoria in Canada. She is based in the foundation’s Washington, DC, office.

Tore Godal, M.D., Ph.D., is an international public health specialist, currently working as a special advisor on global health at the Ministry of Foreign Affairs, Norway. He has facilitated the establishment of a research program for global heath in Norway (Globvac) and global partnerships relating to maternal and child health such as the UN Every Woman Every Child initiative and the Global Financing Facility at the World Bank. As the founding executive secretary of Gavi, Dr. Godal was instrumental in the design and development of this alliance on which the Global Fund was also modeled. Previously, Dr. Godal was instrumental in the initiation of the UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases, leading the program’s pilot project and flagship effort, Immunology of Leprosy. As a director of the Special Programme for Research and Training in Tropical Diseases (TDR), Dr. Godal organized a number of large-scale trials, including on insecticide-treated mosquito nets which showed that African children were saved from dying from malaria if sleeping under a net. Before retiring from WHO, Dr. Godal launched the Roll Back Malaria project. A medical doctor and trained immunologist, Dr. Godal has contributed a great deal to the understanding of mechanisms of immunity to mycobacteria, the pathogenesis of autoimmune disease, and the clinical and subclinical manifestations of leprosy. His research in cancer has led to the development of diagnostic tools, including monoclonal antibodies for leukemia and lymph node cancer. Most recently, Dr. Godal contributed to the initiation and financing of the promising Ebola vaccine trial in Guinea. Dr. Godal has more than 300 publications in peer-reviewed journals.

Eduardo González-Pier, Ph.D., currently serves as the Undersecretary for Integration and Development of the Health Sector in the Ministry of Health of Mexico. He is responsible for overseeing policies and strategies to improve health system performance, including quality assurance for health care services, health technology assessment, metrics and evaluation for health system performance, planning and regulation of human resources for health, as well as the production of statistics and information systems related to the health sector.

Dr. González-Pier has held several positions in the health and social security sectors, including Executive Chairman of the Mexican Health

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Foundation (FUNSALUD), a leading health policy think tank; Chief Financial Officer of the Mexican Social Security Institute (IMSS), the largest insurer and provider of health services in Mexico; and Chief Economist and General Coordinator of Strategic Planning at the Ministry of Health of Mexico. Over the past 20 years, he has been involved in the formulation and implementation of various social security and health financing reform initiatives, most recently the introduction of the System of Social Protection in Health (Seguro Popular de Salud). Dr. González-Pier holds a B.S. from Washington and Lee University and a Ph.D. in economics from the University of Chicago.

Richard Gregory is Senior Policy Adviser, Global Health Security, in DFID. Prior to this he was Senior Health Adviser for DFID and the United Kingdom Joint Inter-Agency Taskforce on Ebola in Sierra Leone, leading UK technical inputs to the national Ebola response and working closely with the government of Sierra Leone on policy and strategy. Previous DFID roles include Regional Health Adviser for Africa, and country postings to Ethiopia and Pakistan.

Daniel Hanna, M.B.A., is Managing Director and Head of Public Sector and Development Organisations for Africa, Americas, Europe and the Middle East, for Standard Chartered Bank. Mr. Hanna has more than 15 years of banking experience in emerging markets, in particular in Africa and the Middle East, and has provided advice to governments, state-owned enterprises, institutions, and companies on raising equity and debt, restructuring their business activities, and investing in emerging markets. He is the rating advisor to several African governments and in 2015 worked with the United Kingdom’s CDC Group for the creation of the USD 50m Post Ebola Reconstruction Facility for Sierra Leone.

Mr. Hanna was previously the co-Head of Wholesale Banking for South Africa and Southern Africa for Standard Chartered based in Johannesburg. He was also the lead author of the Qatar 2020 development report for the Emir of Qatar and a member of the UK China Emerging Leaders Roundtable. He established and ran the UK India CEO Forum for the chairs, Peter Sands and Ratan Tata, under the sponsorship of Prime Ministers David Cameron and Manmohan Singh. Mr. Hanna has previously worked as a visiting Fellow for Chatham House and for the President of the European Parliament. He has master’s in business administration (distinction) from London Business School, a Certificate d’Etudes European from Science Po Strasbourg, and a B.A. in economics and politics from Exeter University.

Erin Hohlfelder joined ONE in January 2010 and serves as the Policy Director for Global Health. In this role, she leads health research and

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

policy analysis across ONE’s global markets, focusing primarily on infectious diseases, maternal and child health, and health financing mechanisms. Since August 2014, she has also led ONE’s organization-wide response to the Ebola outbreak, including the development of an online accountability tool to track donors’ response efforts. Before joining the organization, she worked for the Global Network for Neglected Tropical Diseases at the Sabin Vaccine Institute, where she helped to develop and lead advocacy, social media, community engagement, and legislative efforts around neglected tropical diseases.

Ms. Hohlfelder graduated summa cum laude from the George Washington University with a degree in international affairs and dual concentrations on international politics and African studies. She also spent time living in Kenya, where she conducted research on integrated care models for female AIDS orphans.

Olga Jonas, M.P.A., M.A., has been responsible for coordinating the World Bank Group’s operational response to avian and human pandemic influenza threats and for working with Senior UN Influenza Coordination on monitoring the overall global response since 2006. Among other assignments, she was the lead World Bank author of the joint UN–World Bank global progress reports and delivered presentations on the global response to five ministerial conferences on avian and pandemic influenzas in 2006-2010. Ms. Jonas oversaw the World Bank’s global program for avian influenza response and pandemic influenza preparedness, which provided $1.3 billion to developing countries. This included the Avian and Human Influenza Facility which made grants to countries to improve their public veterinary and human health capacities. She has also addressed other meetings on pandemic threats. Her prior assignments included lead economist work on two replenishments of the International Development Association (IDA), which is a part of the World Bank Group, lead economist of the World Bank/Commonwealth task force on small states, emergency response policy, extractive industries review, and macroeconomic operational work with francophone African countries. Ms. Jonas joined the World Bank Group in 1983 through the Young Professionals Program. Prior to that she held positions at Princeton University, the Bank for International Settlements, and the Organisation for Economic Co-operation and Development. She was educated at Williams College and Princeton.

Patrick W. Kelley, M.D., Dr.P.H., joined the National Academies of Sciences, Engineering, and Medicine in July 2003 as the Director of the Board on Global Health. He was subsequently also appointed the Director of the Board on African Science Academy Development. Dr. Kelley has overseen a portfolio of IOM expert consensus studies and convening activities on

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

subjects as wide ranging as the evaluation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. commitment to global health, sustainable surveillance for zoonotic infections, cardiovascular disease prevention in low- and middle-income countries, interpersonal violence prevention in low- and middle-income countries, and microbial threats to health. He also directs a unique capacity-building effort, the African Science Academy Development Initiative, which over 10 years aims to strengthen the capacity of eight African academies to provide independent, evidence-based advice their governments on scientific matters.

Prior to joining to the Academies Dr. Kelley served in the U.S. Army for more than 23 years as a physician, residency director, epidemiologist, and program manager. In his last U.S. Department of Defense (DoD) position, Dr. Kelley founded and directed the DoD Global Emerging Infections Surveillance and Response System (DoD-GEIS). This responsibility entailed managing surveillance and capacity-building partnerships with numerous elements of the federal government and with health ministries in more than 45 developing countries. He also founded the DoD Accession Medical Standards Analysis and Research Activity. Dr. Kelley is an experienced communicator having lectured in English or Spanish in more than 20 countries. He has published more than 70 scholarly papers, book chapters, and monographs. Dr. Kelley obtained his M.D. from the University of Virginia and his Dr.P.H. in epidemiology from the Johns Hopkins School of Hygiene and Public Health. He is also board certified in preventive medicine and public health.

James F. Kollie, Jr., M.B.A., Ph.D., is Deputy Minister for Fiscal Affairs at the Ministry of Finance and Development Planning of the Republic of Liberia, with responsibility for managing the financial resources of the country, developing and administering financial rules and regulations, overseeing matters relating to government accounting and reporting, overseeing matters relating to tax and revenue policies and reform, and overseeing overall expenditure monitoring. Before becoming Deputy Minister for Fiscal Affairs in 2014, he served as Deputy Minister for Revenues in 2012 at the Ministry of Finance and previously as Acting Deputy Minister for Regional and Sectoral Planning at the Ministry of Planning and Economic Affairs in 2011.

Dr. Kollie comes to his position with a unique combination of experience in the private sector, the not-for-profit sector, and the public sector. He brings a wealth of experience and interest in policy formulation and analysis, program evaluation, finance, and accounting.

In 2009, working with the team at the Ministry of Planning and Economic Affairs, he ran the Secretariat of the Liberia Reconstruction & Development Committee, where he used results-based monitoring techniques

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

to significantly improve implementation rates. During this period, he was instrumental in enhancing coordination between development partners and state actors.

Dr. Kollie’s work with the implementation of the Poverty Reduction Strategy as well as his involvement in the development of Liberia’s National Vision (Liberia Rising 2030) and the 5-year development plan, the Agenda for Transformation, has well positioned him in fully understanding and appreciating the challenges to Liberia’s development as well as what key interventions are required to advance the development goals. Dr. Kollie holds a bachelor’s degree in accounting and economics from Zion University College, an M.B.A. in corporate finance from the University of St. Thomas, and a Ph.D. in public policy and administration from Walden University.

Gunther Kraut, Ph.D., joined the Financial Solutions Life department at Munich Re in 2007. Among various other activities, he has developed a certain focus on pandemic risk transfer. He played a leading role in successfully developing and structuring Munich Re’s global life pandemic risk retrocession program. Dr. Kraut earned a degree in financial mathematics at Technische Universität München before pursuing management studies at Ludwig-Maximilians-Universität München (LMU). While earning his doctoral degree at the Institute for Risk Management and Insurance at LMU, one of Dr. Kraut’s main research areas was the management and regulation of extreme mortality risks.

Chris Lane, M.A., is Chief of the Low-Income Countries Division, Strategy Policy and Review Department at the IMF in Washington, DC. He is responsible for policies relating to IMF lending to and monitoring of low-income countries. In 2015, he led a staff team that proposed a debt relief mechanism for countries hit by public health disasters via “The Catastrophe Containment and Relief Trust.” Debt relief has since been provided to the three countries most impacted by the Ebola outbreak and new financing has been raised for the Trust. Mr. Lane has extensive experience of fund support for low-income and emerging market economies. Other relevant experience includes working as a macroeconomic advisor at WHO in 2007-2008, and research on scaling up health spending in developing countries.

Gordon Liu, Ph.D., M.A., is a Peking University (PKU) Yangtze River Scholar Professor of Economics at Peking University’s National School of Development (NSD), and Director of the PKU China Center for Health Economic Research. His research interests include health and development economics, health reform, and pharmaceutical economics.

Prior to PKU NSD, he was full professor at PKU Guanghua School of Management (2006-2013), associate professor at the University of North

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Carolina at Chapel Hill (2000-2006), and assistant professor at the University of Southern California (1994-2000). He was the 2005-2006 President of the Chinese Economists Society, and the founding chair of the Asian Consortium for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Dr. Liu has served as Associate Editor for Science Citation Indez journals Health Economics (HE), Value in Health (the ISPOR official journal), and China Economic Quarterly. Dr. Liu sits on the China State Council Health Reform Advisory Commission, the UN “Sustainable Development and Solution Network” (SDSN) Leadership Council led by Jeffrey Sachs of Columbia University, and co-chairs the SDSN Health Thematic Group.

Nita Madhav, M.S.P.H., is a Principal Scientist in the Research and Modeling group at AIR Worldwide, where she leads the life and health risk research and modeling team. In this role, she has directed development of AIR’s pandemic disease risk models. Since joining AIR in 2005, she has also developed industry exposure databases, created global historical loss databases, and provided planning and logistical support for post-disaster damage surveys. Prior to AIR, Ms. Madhav worked in the Special Pathogens branch of CDC. She earned her B.S. in ecology and evolutionary biology, with distinction, from Yale University, and her M.S.P.H. in epidemiology from the Rollins School of Public Health at Emory University. Her background is in the epidemiology of vector-borne and zoonotic diseases, and the statistical modeling of disease spread.

Olivier Mahul, Ph.D., is the Program Manager of the World Bank’s Disaster Risk Financing and Insurance Program, which is co-sponsored by the World Bank, the Global Facility for Disaster Reduction and Recovery (GFDRR), the Swiss State Secretariat for Economic Affairs, the Ministry of Finance of Japan, and the Ministry of Foreign Affairs of the Netherlands. This program mainstreams disaster risk financing and insurance within the disaster risk management and climate change adaptation agenda in developing countries. Since he joined the World Bank in 2003, Dr. Mahul has been involved in developing disaster risk financing and insurance solutions in more than 40 countries, including Colombia, Costa Rica, India, Indonesia, Mexico, Mongolia, and Vietnam. Dr. Mahul was closely involved in the product development of the World Bank catastrophe drawdown option (CAT DDO), a contingent credit line that provides immediate liquidity to World Bank member countries in the aftermath of natural disasters. The CAT DDO has been approved for several countries, including Colombia, Costa Rica, and the Philippines. Dr. Mahul is one of the key architects of the Caribbean Catastrophe Risk Insurance Facility, which provides the Caribbean island states with parametric insurance against major natural

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

disasters. He is currently co-leading the Pacific Catastrophe Risk Assessment and Financing Initiative, which offers the Pacific island countries risk assessment and modeling tools to guide their disaster risk management decisions and their disaster risk financing strategies. Dr. Mahul is one of the program designers of the Mongolia Index-based Livestock Insurance Program, an index-based livestock mortality insurance program against extreme weather events. Dr. Mahul also provides the government of India with advisory services on the reform of the India’s National Agricultural Insurance Scheme, the world’s largest crop insurance program in terms of farmers insured. Dr. Mahul holds a Ph.D. in economics from Toulouse School of Economics and post-doctorates from Wharton Business School and University of California, Berkeley. Dr. Mahul has authored more than 40 publications in international journals and won several academic awards. He recently co-authored two books: Catastrophe Risk Financing in Developing Countries: Principles for Public Intervention (with J. David Cummins) and Government Support to Agricultural Insurance: Challenges and Options for Developing Countries (with Charles Stutley).

Lelio Marmora, J.D., is the Executive Director of UNITAID. He joined in October 2014 from the Global Fund to Fight AIDS, Tuberculosis and Malaria, where he spent the previous 7 years, most recently as Head, Africa and Middle East Department. In this role he coordinated 170 staff across 4 regional teams and managed a $8 billion portfolio for 48 countries. Prior to the Global Fund, Mr. Marmora spent 7 years with the World Bank, where he focused on fundraising, resource mobilization, and program design.

A lawyer by training, Mr. Marmora has also worked at a variety of other international organizations such as UN Educational, Scientific and Cultural Organization (UNESCO) and UNDP, as well as for the government in his native Argentina.

Martin Meltzer, M.Sc., Ph.D., is the Lead of the Health Economics and Modeling Unit, and a Distinguished Consultant in the Division of Preparedness and Emerging Infections, CDC, in Atlanta, Georgia. He received his undergraduate degree from the University of Zimbabwe in 1982, and master’s and a doctorate in applied economics from Cornell University, New York, in 1987 and 1990, respectively. From 1990 to mid-1995, he was on the faculty at the College of Veterinary Medicine at the University of Florida. In 1995, he moved to CDC, where he was in the first class of Prevention Effectiveness (health economists) Fellows. He led the modeling teams supporting CDC’s response to the 2009 H1N1 influenza pandemic, including producing monthly estimates of cases, hospitalizations, and deaths, as well as estimating impact of the vaccination program and use of influenza antiviral drugs. Other responses in which he led the modeling activities

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

include estimating the residual risk associated with the 2012 contaminated steroid injectable products that caused fungal meningitis among patients, and the 2014 Ebola epidemics in West Africa. Examples of his research include estimating the impact of the 2009 influenza pandemic, the modeling of potential responses to smallpox as a bioterrorist weapon, and assessing the economics of controlling diseases such as rabies, dengue, hepatitis A, meningitis, Lyme, and malaria. Dr. Meltzer has published approximately 210 publications, including more than 100 papers in peer-reviewed scientific journals and more than 34 software tools. These tools include FluAid, FluSurge, and FluWorkLoss, designed to help state and local public health officials plan and prepare for catastrophic infectious disease events. They have been downloaded more than 100,000 times and have been used by local, state, national, and international public health agencies, with jurisdictions exceeding a total of 1 billion persons. Dr. Meltzer is an associate editor for Emerging Infectious Diseases. He also supervises a number of post-doctoral health economists at CDC.

Nachiket Mor, Ph.D., M.B.A., is the chairman of the board of CARE India, a board member of the Reserve Bank of India, and a board member of CRISIL. He has a background in finance and economics with a specific interest in financial access and health care. Dr. Mor worked with ICICI, India’s second largest bank, from 1987 to 2007 and was a member of its Board of Directors from 2001 to 2007. From 2007 to 2011, he served as the founding president of the ICICI Foundation for Inclusive Growth and during this period was also the chair of the Governing Council of IFMR Trust and board chair of FINO, both leading participants in the field of financial inclusion in India. While at ICICI he also served as a board member of Wipro for 5 years and as board chair of the Fixed Income Money Market and Derivatives Association of India for 2 years. During 2011-2012 he served as a member of the High Level Expert Group on Universal Health Coverage for India appointed by the Planning Commission of India, and during 2012-2013 as a member of the health subcommittee of the National Advisory Council of the Government of India. Dr. Mor is currently also a member of the Board of Directors of the IKP Centre for Technologies in Public Health and Sughavazhvu Healthcare. Dr. Mor is a Yale World Fellow, has a Ph.D. in economics from the University of Pennsylvania with a specialization in finance from the Wharton School, an M.B.A. from the Indian Institute of Management, Ahmadabad, and an undergraduate degree in physics from the Mumbai University.

Carmen (Ceci) Mundaca-Shah, M.D., Dr.P.H., is a Senior Program Officer with the Board on Global Health of the National Academies of Sciences, Engineering, and Medicine. She is currently directing the Multi-Stakeholder

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Initiative for Creating and Operational Global Health Risk Management Framework for the 21st Century. Prior to directing this study, she was the study director for the Board on the Health of Select Populations report Beyond Myalgic Encelphalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness, and she served as a post-doctoral fellow with the Board on Global Health on the Outcome and Impact Evaluation of Global HIV/AIDS Programs Implemented Under the Lantos-Hyde Act of 2008. Prior to joining the Academies, Dr. Mundaca-Shah was employed as head of the Surveillance Center of the Emerging Infections Program in the U.S. Naval Medical Research Unit 6 in Lima, Peru. In that role, she led the successful implementation of a technology-based disease surveillance system (Alerta) at sites across the nation and initiated the broad adoption of Alerta in five other countries in South America. Alerta is a partnership involving the Peruvian Navy and the U.S. Navy. Dr. Mundaca-Shah also led the collaborative syndromic surveillance pilot implementation in the Peruvian Ministry of Health. She was part of the Early Warning Outbreak Recognition System Working Group and participated in several studies, including a field visit to evaluate the performance of the system in Lao People’s Democratic Republic. She obtained her M.D. from San Marcos University, Lima, Peru, and her M.P.H. and Dr.P.H. degrees from the Uniformed Services University of the Health Sciences, Bethesda, Maryland. Her dissertation work focused on developing a framework to guide the implementation of disease surveillance systems in developing countries. Dr. Mundaca-Shah completed a certificate in emerging infectious disease epidemiology at the University of Iowa.

David Nabarro, B.M.B.Ch., M.A., M.Sc., MFPHM, FRCP, is the UN Secretary-General’s Special Envoy on Ebola. Since his appointment in September 2014, Dr. Nabarro has worked on behalf of the UN system to provide the overarching strategic and policy direction for a greatly enhanced international response to the West Africa Ebola Outbreak. This includes galvanizing essential support for affected communities and countries from partners around the world. Dr. Nabarro concurrently serves as Special Representative of the UN Secretary-General for Food Security and Nutrition and as Coordinator of the Movement for Scaling Up Nutrition, positions he has held since 2009 and 2012, respectively. These appointments follow an extensive career in global health, nutrition, and development, beginning as a District Child Health Officer in Dhankuta District, Nepal. Since then, Dr. Nabarro has played a catalytic coordination role in the response to several global emergencies, such as the avian and human influenza epidemic of 2005, and crisis response operations in Darfur, Sudan, and in countries affected by the 2004 Indian Ocean earthquake and tsunami.

Dr. Nabarro has lived and worked in government, the UN, NGOs, and academic institutions in Bangladesh, Iraq, Kenya, Nepal, and the United

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Kingdom, as well as at UN Headquarters in Geneva and New York. Previous key leadership roles include Coordinator of the UN System High Level Task Force on Global Food Security (2008-2014), Senior UN Coordinator for Avian and Pandemic Influenza (2005-2014), Representative of the WHO Director-General for Health Action in Crises (2003-2005), Executive Director, Office of the WHO Director-General (2001-2003), Head of Roll Back Malaria at WHO (1999-2001), and Director for Human Development in the DFID (1997-1999).

Dr. Nabarro was awarded an M.A., an M.Sc., and a medical degree from Oxford University. He also holds a master’s in public health from London University. He is a Fellow of the Royal College of Physicians, and in 1982 was appointed a CBE in recognition of his international public service. He speaks three languages, including French and Nepali.

Frances Reid, Ph.D., J.D., joined CDC Group plc in November 2014, coming from the Millennium Challenge Corporation in Washington, DC, where she was Senior Investment and Risk Officer in the Office of the Chief Executive. She brings to CDC Group extensive experience in investment and finance across global emerging markets. She previously served in senior positions in the U.S. Department of the Treasury, the European Bank for Reconstruction and Development, Lehman Brothers, and Bank of Boston. Dr. Reid’s experience covers a range of financial activities, including corporate finance, private equity, investment management, debt restructuring, and development of proprietary financial products. Much of her work has been in emerging markets, particularly in Africa, Asia, and Eastern Europe. She has advanced degrees in both economics and law.

Peter Sands, M.P.A., stepped down from the role of Standard Chartered PLC’s Group Chief Executive in June 2015, having been appointed to the role in November 2006. He joined the board of Standard Chartered PLC as Group Finance Director in May 2002, responsible for Finance, Strategy, Risk and Technology, and Operations. Prior to this, Mr. Sands was Director and Senior Partner at worldwide consultants McKinsey & Co. Before joining McKinsey, Mr. Sands worked for the United Kingdom’s Foreign and Commonwealth Office.

Mr. Sands is the lead non-executive board member of the Department of Health in the United Kingdom and the co-chair of the India UK CEO Forum. Mr. Sands has held a number of board memberships including the Institute of International Finance and the International Monetary Conference. He is a member of the Global CEO Council set up by the Chinese People’s Association for Friendship with Foreign Countries to advise the Chinese government and served on the Monetary Authority of Singapore’s International Advisory Panel. He graduated from Oxford University and

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

holds a master’s in public administration from Harvard University, where he was a Harkness Fellow.

Paolo Sison, M.Sc., M.B.A., is Director for Innovative Finance at Gavi, the Vaccine Alliance. Gavi is a public–private partnership committed to saving lives and protecting people’s health by increasing access to immunization in poor countries, and is a leading force in innovative finance for development. Gavi’s innovative finance mechanisms include IFFIm, the Pneumococcal Advance Market Commitment, and the Gavi Matching Fund.

Before joining Gavi, Mr. Sison spent 10 years in investment banking in London, most recently as Director, Global Banking and Markets, at HSBC, where he was responsible for equity and equity-linked origination in the financial services sector across Europe, the Middle East, and Africa. His capital markets experience includes fixed income, hybrid and derivative origination, and structuring. Previously, he spent 6 years in Manila and in Tokyo, with Ayala Corporation’s Strategic Planning Group and with Mitsubishi Corporation’s Development & Coordination Department. During this time he looked after the business groups’ investments in the financial services and industrial sectors, and was actively involved in business development in the Asia-Pacific region. Mr. Sison holds an M.Sc. in finance from London Business School and an M.B.A. from the Asian Institute of Management.

Trish Stroman, M.B.A., M.S., is a Partner in Boston Consulting Group’s (BCG’s) Washington, DC, office. Since joining BCG in 2005, her focus has been on health care, with a particular focus in global public health and health services. Ms. Stroman most recently supported the UN Mission for Ebola Emergency Response team with the strategy, planning, and management of the latest outbreak, including aid to the Secretariat during initial mission design and direct support to mission leadership in Accra. Following the Ebola crisis, she worked in collaboration with the World Economic Forum to assess opportunities for improved public–private collaboration in health emergencies. In addition, Ms. Stroman helped to create a business plan for African Risk Capacity, a specialized agency of the African Union, to develop a new insurance product to cover disease outbreaks and epidemics.

In her work with foundations, public–private partnerships, and public-sector entities, Ms. Stroman aims to bring BCG’s cutting-edge knowledge to bear, with an eye toward customizing their approach to meet the needs of complex stakeholder environments and long-term, intractable problems like HIV/AIDS or malaria. Ms. Stroman holds an M.B.A. and an M.S. in public health from the University of North Carolina at Chapel Hill and a B.A. in human biology from Stanford University. Prior to joining BCG,

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

Ms. Stroman was an internal consultant for the physician group at Kaiser Permanente in Northern California.

Jordan W. Tappero, M.D., M.P.H., is Director of the Division of Global Health Protection (DGHP), Center for Global Health, CDC. DGHP is CDC’s most visible program for strengthening global health security and developing public health capacity to prevent, detect, and respond to communicable and noncommunicable disease threats around the world. DGHP builds capacity in applied epidemiology through field epidemiology training programs and fosters the development of National Public Health Institutes with Ministries of Health globally. In the event of a global disease epidemic or humanitarian disaster, DGHP often leads CDC global response. Throughout 2015, Capt. Tappero has been leading CDC’s newly funded ($1 billion) Global Health Security Agenda and International Ebola emergency funding efforts, traveling to sub-Saharan Africa and South Asia to open offices there, as well as in South Asia. As a leader in CDC’s West African Ebola Response, Capt. Tappero served in Liberia from August to September 2014 as the first CDC Lead for the Public Health and Medical Response within USAID’s Disaster Assistance Response Team for West Africa. From late September 2014 through January 2015, he served as Deputy Incident Manager for the Ebola Response out of CDC’s EOC, where he assisted with directing the day-to-day international and domestic response activities. Capt. Tappero also led CDC’s emergency response following the 2010 Haiti earthquake and follow-on response to epidemic cholera. Capt. Tappero joined CDC in July 1992 as an Epidemic Intelligence Service Officer, is a Captain in the U.S. Public Health Service, and holds three American Board Certifications and a master’s in public health from the University of California, Berkeley. He has authored or co-authored more than 250 peer-reviewed publications, as well as textbook chapters on HIV, TB, malaria, meningococcal disease, leptospirosis, Ebola and Marburg hemorrhagic fevers, cholera, and other emerging infections.

Hans Troedsson, M.D., has a medical degree and has worked as a physician in the areas of pediatrics, infectious diseases, and public health in Sweden. He has 20 years’ experience of international health at country and global levels. He joined WHO in 1990 and worked in the African Region, South-East Asia Region, Western Pacific Region, and at Headquarters (HQ). He has a vast experience of technical support to regions and countries as well as in the area of research and development at the global level. In the past, he was responsible for coordinating collaboration between the WHO HQ Department of Child and Adolescent Health and Development (CAH) and the World Bank, as well as with other key partners both at country and global levels.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

He knows international development cooperation from his work as the Deputy Head of Health Division at Sida in 1995-1997, and as the Project Leader for the development of Sida’s Policy for Development Cooperation in the Health Sector. He held the position of Team Coordinator Health Services Delivery in the CAH at WHO/HQ, before he was appointed Director of the Department in 2000. He was WHO Representative in Vietnam from 2004 to 2007 when he actively contributed to avian influenza control and preparedness and health system reforms in the country.

From 2007 to 2009 he was WHO Representative in China in charge of WHO support to the government of China during several main events such as the earthquake in Sichuan, the Olympic Games in Beijing, the melamine food contamination incident, and the early stages of the influenza H1N1 pandemic. In September 2009 he was appointed Director, Programme Management, at the WHO Western Pacific Regional Office in Manila. Dr. Troedsson was the Executive Director of the Director-General’s Office from November 2012 through February 2014. Dr. Troedsson was appointed Assistant Director-General for General Management in March 2014.

Panos Varangis, Ph.D., is the global head of IFC Access to Finance SME & Business Advisory Services. He is also the global product specialist for projects with financial institutions in agriculture finance. Before joining IFC, Dr. Varangis served as the Deputy CEO of the Agricultural Bank of Greece for 5 years. He oversaw the corporate, small and medium enterprise (SME), and non-performing loan (NPL) department at the bank, and served on the Board of Directors of the Agricultural Insurance Company, the credit card and mutual fund companies of the bank, as well as on the Board of Directors of ATE Bank, Romania. Prior to this, Dr. Varangis worked for 17 years at the World Bank in various positions at the International Commodities Division, the International Trade Division, and the Research Department and finally at the Agricultural and Rural Development Department where he oversaw a global program on commodity risk management. His work at the World Bank focused on issues related to agricultural policies, commodity marketing systems, rural finance, and risk management. He has published a number of working papers, articles in journals, and chapters in books. He holds a Ph.D. in international economics from Columbia University, New York, and a master’s degree in economics from Georgetown University.

José Ángel Villalobos, M.B.A., M.Sc., is originally from Costa Rica. He is an affiliate member of the Institute and Faculty of Actuaries (UK), associate member (actuary) of the Colegio de Profesionales en Ciencias Económicas (CRI), associate member of the Chartered Insurance Institute (UK), and a Chartered Property and Casualty Underwriter (USA). He is a holder of an

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

M.B.A. and an M.Sc. (Actl), both from Heriot Watt University, Scotland. Mr. Villalobos has more than 30 years of experience in the (re)insurance sector (life and non-life) and 3 years working for the World Bank. His current position is Senior Insurance Specialist, Disaster Risk Financing & Insurance Program, Global Practice for Finance and Markets (GFMDR) and Global Facility for Disaster Reduction and Recovery (GFDRR), and he is serving the countries of Latin America and Southeast Asia.

Staci Warden, M.P.P., is the executive director of the Center for Financial Markets at the Milken Institute, where she leads initiatives on strengthening capital markets, access to capital, financial education, and financial-markets solutions, among others. Ms. Warden is chair of the Rwandan Capital Markets Authority. Prior to joining the Milken Institute, she spent 6 years with JPMorgan in London, where she ran JP Morgan’s Central Bank client franchise in Europe, Eurasia, and Africa, and 2 years in New York as part of the sovereign-debt-restructuring deal team. Before joining JP Morgan, she was a director at the Nasdaq, where she led their two initiatives for microcap companies, the Bulletin Board Exchange (BBX) and the Over-The-Counter Bulletin Board (OTCBB).

Ms. Warden has spent many years in the not-for-profit and public sectors managing, advising, and writing on issues of international economic development. At the U.S. Department of the Treasury, she ran the international debt-for-nature swap program and participated in the Argentina debt-restructuring and heavily indebted poor countries initiatives. In the not-for-profit sector, she served as startup chief operating officer of the Center for Global Development, an associate in the economic-reform program at the Carnegie Endowment for International Peace, and a development associate at the Harvard Institute for International Development. She has worked or done business in more than 50 countries and has served as an advisor to several ministers of finance on sovereign-wealth management, debt management, and poverty reduction.

Ms. Warden holds a master’s of public policy from the Kennedy School of Government at Harvard University, with a concentration in international trade and finance, and has completed her coursework for a Ph.D. in economics from Brandeis University.

Nathan Wolfe, M.A., D.Sc., is the founder and CEO of Metabiota, the pioneering risk analytics company that improves the world’s resilience to epidemics. He holds the Lorry I. Lokey Business Wire Consulting Professorship in Human Biology at Stanford University. Dr. Wolfe received his doctorate in immunology and infectious diseases from Harvard in 1998. He was the recipient of a Fulbright fellowship in 1997 and the National Institutes of Health Director’s Pioneer Award in 2005. He was named a

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

World Economic Forum Young Global Leader in 2009, a National Geographic Emerging Explorer in 2010, and one of the Time 100 in 2011. Dr. Wolfe has published 90 technical articles and book chapters. His first book, The Viral Storm, has been published in six languages and was shortlisted for the Royal Society’s Winton Prize. His work has been published in or covered by Nature, Science, Lancet, Proceedings of the National Academy of Sciences of the United States of America, JAMA, The New York Times, The Economist, The Wall Street Journal, TechCrunch, Wired, Scientific American, NPR, The New Yorker, National Geographic Magazine, and Forbes. Dr. Wolfe has more than 8 years of experience living and conducting biomedical research in Southeast Asia and sub-Saharan Africa. His endeavors have attracted grant, contract, and investment support totaling more than $100 million.

Gordon Woo, Ph.D., is a catastrophist at Risk Management Solutions (RMS), specializing in the quantitative analysis of extreme risks and disaster finance. In his 15 years at RMS, Dr. Woo has designed computer models for numerous catastrophes, including pandemics. For his work on catastrophe insurance, he was named by Treasury and Risk magazine as 1 of the 100 most influential people in finance. In response to the Ebola crisis, he has been engaged in developing initiatives for funding pandemic risk mitigation.

He is the author of the book Calculating Catastrophe, published by Imperial College Press. Dr. Woo was educated at Cambridge and Massachusetts Institute of Technology, and was a member of the Harvard Society of Fellows. He is a visiting professor at University College London, and an adjunct professor at Nanyang Technological University, Singapore.

Prashant Yadav, Ph.D., M.B.A., is a Senior Research Fellow at the William Davidson Institute (WDI) and Vice President of the Health Care Research Initiative at WDI. He also holds faculty appointments at the Ross School of Business and the School of Public Health at the University of Michigan. A leading expert on pharmaceutical and health care supply chains in developing countries, Dr. Yadav’s research explores the functioning of health care supply chains using a combination of empirical, analytical, and qualitative approaches. He serves as an advisor in the area of pharmaceutical supply chains to The Bill & Melinda Gates Foundation, World Bank, WHO, UK Department for International Development, and many other global health organizations. He is the author of many scientific publications and his work has been featured in prominent print and broadcast media, including The Economist, The Financial Times, Nature, and BBC. He served as a member of the Institute of Medicine’s committee on strengthening food and drug regulation in developing countries and as an advisory board member of several public–private partnerships, and currently serves as co-chair

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

of the Procurement and Supply Chain Working Group of the Roll Back Malaria Partnership. Prior to coming to the William Davidson Institute at the University of Michigan, Dr. Yadav was a professor of supply chain management at the Massachusetts Institute of Technology (MIT)-Zaragoza International Logistics Program and a research affiliate at the MIT Center for Transportation and Logistics, where he led the creation of a high-impact research initiative focused on pharmaceutical supply chains in developing countries. From 2008 to 2010 he was also a visiting scholar at the INSEAD Social Innovation Center. Dr. Yadav received his Ph.D. from the Manderson Graduate School of Business at the University of Alabama. He received his M.B.A. from the Foundation for Organisational Research and Education (FORE) School of Management and his bachelor of chemical engineering from the Indian Institute of Technology.

Simon Young, Ph.D., has a background in earth sciences, with a specialization in volcanology. For the past 15 years he has worked as a consultant, providing a broad range of disaster and climate risk management and financing services around the world in both private and public sectors. Between 2006 and 2013, that work was undertaken as CEO of Caribbean Risk Managers Ltd, where Dr. Young was closely involved in the development, implementation, and operations of both the Caribbean Catastrophe Risk Insurance Facility (CCRIF) and the Microinsurance Catastrophe Risk Organisation (MiCRO). Most recently, Dr. Young has been managing CCRIF’s expansion into Central America and the implementation of its Excess Rainfall product, and he also represented CCRIF on the deal team for the CCRIF/International Bank for Reconstruction and Development (IBRD) catastrophe bond placed in July 2014.

During 2013 and early 2014 he was lead Advisor to the African Risk Capacity Insurance Company (ARC Ltd) during its startup phase and was formally appointed CEO in July 2014, a position he still holds. He has also been ARC Ltd.’s Underwriter, managing the insurance underwriting process and supporting the company’s interactions with the international risk markets.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×

This page intentionally left blank.

Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 85
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 86
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 87
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 88
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 89
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 90
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 91
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 92
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 93
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 94
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 95
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 96
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 97
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 98
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 99
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 100
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 101
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 102
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 103
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 104
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 105
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 106
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 107
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 108
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 109
Suggested Citation:"Appendix C: Participant Biographies." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Pandemic Financing: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21855.
×
Page 110
Global Health Risk Framework: Pandemic Financing: Workshop Summary Get This Book
×
Buy Paperback | $45.00 Buy Ebook | $35.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond the three hardest-hit countries and beyond the health sector. Education, child protection, commerce, transportation, and human rights have all suffered. The consequences and lethality of Ebola have increased interest in coordinated global response to infectious threats, many of which could disrupt global health and commerce far more than the recent outbreak.

In order to explore the potential for improving international management and response to outbreaks the National Academy of Medicine agreed to manage an international, independent, evidence-based, authoritative, multistakeholder expert commission. As part of this effort, the Institute of Medicine convened four workshops in summer of 2015 to inform the commission report. The presentations and discussions from the Pandemic Financing Workshop are summarized in this report.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!